The Denver Post - - BUSINESS -

The Con­sumer Fi­nan­cial Pro­tec­tion Bureau roughly dou­bled the num­ber of en­force­ment cases it brought last year as the fed­eral watch­dog in­ten­si­fied its scru­tiny of in­dus­tries, in­clud­ing credit cards, auto lend­ing and debt col­lec­tion.

CFPB of­fi­cials said that in 2015 the bureau han­dled 59 cases in which com­pa­nies set­tled al­le­ga­tions of wrong­do­ing and 11 cases that led to law­suits. That com­pares with 23 set­tle­ments and 11 law­suits for 2014, and 21 set­tle­ments and seven law­suits in 2013.

The sharp in­crease re­flects the growth in the num­ber of in­ves­ti­ga­tors, ex­am­in­ers and ad­min­is­tra­tive staffers, as well as ma­tur­ing of the bureau’s prac­tices and poli­cies four years af­ter it was es­tab­lished un­der the Dod­dFrank fi­nan­cial over­haul law.

Den­ver com­pany for­feits N.D. oil. Reg­u­la­tors or­dered

a Den­ver com­pany to for­feit crude oil that was ob­tained from an area where it did not hold a lease. The North Dakota In­dus­trial Com­mis­sion on Mon­day or­dered Gadeco LLC to for­feit the 800 bar­rels of oil. Pro­ceeds from the sale of the oil will go into the state’s gen­eral fund. State Min­eral Re­sources di­rec­tor Lynn Helms says the com­pany drilled in er­ror. The com­pany spent more than $8 mil­lion drilling the well, which is now plugged.

United warns of pas­sen­ger yield slide. United

Con­ti­nen­tal Hold­ings Inc. is pro­ject­ing a larger de­cline in a key pas­sen­ger­rev­enue met­ric, cit­ing, among other things, travel cuts from oil-patch cor­po­rate cus­tomers. Yield is the av­er­age price a per­son pays to fly one mile, ex­clud­ing taxes and fees.

On Mon­day, the car­rier said unit rev­enue, or how much it makes for each pas­sen­ger flown a mile, would de­cline 4.4 to 4.5 per­cent for the year ended Dec. 31, com­pared with its pre­vi­ous view of a 3.9 to 4.4 per­cent de­cline. Traf­fic, how­ever, rose 1.5 per­cent for the year, bol­stered by a 3.1 per­cent in­crease in the fourth quar­ter.

$300 mil­lion bid for Amer­i­can Ap­parel in.

An in­vestor group wants to buy Amer­i­can Ap­parel for about $300 mil­lion and bring back the cloth­ing chain’s founder and for­mer CEO, Dov Char­ney. Hagan Cap­i­tal Group and Sil­ver Creek Cap­i­tal Part­ners say Char­ney has a busi­ness plan that would im­prove Amer­i­can Ap­parel. The Los An­ge­les com­pany filed for Chap­ter 11 bank­ruptcy pro­tec­tion in Oc­to­ber.

Shire sweet­ens Bax­alta of­fer. Ir­ish drug­maker

Shire PLC’s se­cond at­tempt to buy Bax­alta looks more likely to suc­ceed, with Bax­alta’s board back­ing the sweet­ened of­fer of $32 bil­lion in cash and stock. If the deal goes through, the com­bined com­pany would be one of the world’s top 20 drug­mak­ers by rev­enue and a leader in the niche of raredis­ease medicines.

Treat­ments for dis­eases af­fect­ing fewer than 200,000 Amer­i­cans are a lu­cra­tive re­search area, with drug­mak­ers test­ing hun­dreds in clin­i­cal tri­als. The surge is driven by a com­bi­na­tion of tax breaks, the lure of ul­tra-high drug prices, sci­en­tific ad­vances such as the map­ping of the hu­man genome and ad­vo­cacy groups for pa­tients rais­ing money to en­tice small drug de­vel­op­ers to re­search treat­ments for their con­di­tion.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.